tsh biopharmoration Ltd Cash Flow-to-Debt Ratio
tsh biopharmoration Ltd cash flow-to-debt ratio. tsh biopharmoration Ltd (8432) has a Cash Flow-to-Debt Ratio of 0.16x as of June 2025, meaning its operating cash flow of NT$42.55 Million could theoretically repay 0% of its total liabilities (NT$273.54 Million) in one year. Check tsh biopharmoration Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of tsh biopharmoration Ltd (2017–2024)
Cash flow-to-debt ratio of tsh biopharmoration Ltd from 2017 to 2024. Historical debt coverage capacity for tsh biopharmoration Ltd across 8 annual periods. Check 8432 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
tsh biopharmoration Ltd Cash Flow-to-Debt Ratio by Year (2017–2024)
tsh biopharmoration Ltd cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for tsh biopharmoration Ltd. For the full cash flow conversion analysis, see cash flow conversion of tsh biopharmoration Ltd.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.84x | NT$183.77 Million | NT$219.22 Million | ▲ +230.7% |
| 2023 | 0.25x | NT$33.87 Million | NT$133.63 Million | ▲ +64.2% |
| 2022 | 0.15x | NT$34.35 Million | NT$222.46 Million | ▼ -80.7% |
| 2021 | 0.80x | NT$68.71 Million | NT$85.80 Million | ▲ +610.6% |
| 2020 | 0.11x | NT$11.61 Million | NT$103.04 Million | ▼ -82.4% |
| 2019 | 0.64x | NT$88.65 Million | NT$138.79 Million | ▲ +1.4% |
| 2018 | 0.63x | NT$62.62 Million | NT$99.44 Million | ▲ +4.8% |
| 2017 | 0.60x | NT$81.13 Million | NT$135.08 Million | — |